Company Spotlight – Precede Bio
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Now Available: Spotlight on Stilla Technologies Remi Dangla, PhD – CEO. Click here to read.
Precede Biosciences is embracing comprehensive epigenomics to help drive personalized medicine.
Lightcast controls microdroplets with light to create a fast, flexible experimental platform.
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round.
Stilla Technologies, the start-up leading innovations in digital PCR, announced it has closed a $26.5 million Series C financing.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.